Cancer Research Institute News

Unsung hero of science lends her voice to cancer patients

UniSA radiation therapist Dr Michala Short has been named South Australia’s Unsung Hero of Science for 2021, acknowledging her 20-year career helping to...

New drug offers hope for pancreatic cancer patients

A world first drug developed by UniSA scientists may provide the breakthrough for 500,000 people diagnosed with pancreatic cancer.

UniSA awarded $5.2 million to fight glioblastoma, breast cancer, diabetic foot ulcers and multiple myeloma

Four UniSA researchers have collectively won $5.2 million in Federal Government funding to tackle some of the biggest health issues facing Australia.

UniSA lung health expert takes the Oscar for Australia’s emerging leader in science

A UniSA researcher who “just scraped through high school” was last night named Australia’s emerging leader in science for her commitment to lung health and a...

Scientist of the Year awarded $2.9m to help six million Australians

South Australian Scientist of the Year, UniSA Professor Sharad Kumar, has been awarded $2.9 million to help improve the lives of approximately six million...

Why ovarian cancer outcome shouldn’t be a toss of the coin

How many of you would wager your life on a coin toss? Sadly, that’s the odds that approximately 300,000 women diagnosed with ovarian cancer this year will...

Cancer trials

From bench to bedside, the journey towards new cancer therapies is full of challenges. Clinical trials – where new treatments are tested on people – are vital,...

The Great Outdoors: Citizen Science puts healthy ageing on the map

A spot of sunshine, a love of nature, and a desire to make a difference – it’s a simple combination, but together, these three elements could be key to...

Fighting fungal infections: Giant leaps for smart nanotech

They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists...

Biotech firm seeks to raise $10 million to progress its Covid-19 vaccine candidate

Adelaide-based biotechnology company Sementis is seeking to raise up to $10 million from its shareholders to accelerate work on its next generation Covid-19...